Hochschulschrift
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
XI, 112 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Literaturverzeichnis Seite 95-105
Enthält deutsche und englische Zusammenfassung
Johannes Gutenberg-University Mainz, Dissertation, 2024
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wann)
-
[2024]
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:13 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- [2024]
Ähnliche Objekte (12)
KRAS mutations in squamous cell carcinomas of the lung
Targeting mutant KRAS in pancreatic cancer: futile or promising?
HNSCC: tumour antigens and their targeting by immunotherapy
Targeting a defective DNA damage response in KRAS-mutant adenocarcinomas
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Immunotherapy in 2020 : visions and trends for targeting inflammatory disease
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
"KRAS
Kras
KRAS mutations in squamous cell carcinomas of the lung
Targeting mutant KRAS in pancreatic cancer: futile or promising?
HNSCC: tumour antigens and their targeting by immunotherapy
Targeting a defective DNA damage response in KRAS-mutant adenocarcinomas
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Immunotherapy in 2020 : visions and trends for targeting inflammatory disease
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
"KRAS
Kras
KRAS mutations in squamous cell carcinomas of the lung
Targeting mutant KRAS in pancreatic cancer: futile or promising?
HNSCC: tumour antigens and their targeting by immunotherapy
Targeting a defective DNA damage response in KRAS-mutant adenocarcinomas
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Immunotherapy in 2020 : visions and trends for targeting inflammatory disease
Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
"KRAS